ES2076247T3 - Derivados de la pteridina farmaceuticamente eficaces. - Google Patents

Derivados de la pteridina farmaceuticamente eficaces.

Info

Publication number
ES2076247T3
ES2076247T3 ES90107110T ES90107110T ES2076247T3 ES 2076247 T3 ES2076247 T3 ES 2076247T3 ES 90107110 T ES90107110 T ES 90107110T ES 90107110 T ES90107110 T ES 90107110T ES 2076247 T3 ES2076247 T3 ES 2076247T3
Authority
ES
Spain
Prior art keywords
radical
carbon atoms
denotes hydrogen
alkyl radical
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90107110T
Other languages
English (en)
Inventor
Ernst Prof Dr Dr Mutschler
Angelika Dr Christner
Ingrid Dr Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Roehm GmbH Darmstadt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm GmbH Darmstadt filed Critical Roehm GmbH Darmstadt
Application granted granted Critical
Publication of ES2076247T3 publication Critical patent/ES2076247T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL INVENTO CONCIERNE A LOS COMPUESTOS DE PTERIDINA ACTIVOS COMO FARMACOS, DE FORMULA I (FORMULA), EN LA QUE A SIGNIFICA UN RESTO DE HIDROCARBURO, EVENTUALMENTE SUSTITUIDO, CON 1 A 8 ATOMOS DE C, QUE CONTIENE UN RESTO R3-C-R3 UNIDO DIRECTAMENTE AL RESTO FENILO Y R1 SIGNIFICA HIDROGENO, O UN RESTO CICLOALQUILO CON UN MAXIMO DE 7 ATOMOS DE C FORMANDO CICLO, O UN RESTO ALQUILO CON 1 A 5 ATOMOS DE C, O UN RESTO BENCILO, O UN RESTO AROMATICO AR; R2 ES HIDROGENO, O UN RESTO ALQUILO CON 1 A 8 ATOMOS DE C, O BIEN R1 Y R2, EVENTUALMENTE INCLUYENDO OTROS HETEROATOMOS DEL GRUPO FORMADO POR NITROGENO, OXIGENO O AZUFRE, FORMAN UN HETEROCICLO DE 5 O 6 ESLABONES; R3 SIGNIFICA HIDROGENO O UN RESTO ALQUILO CON 1 A 3 ATOMOS DE C; R3 ES HIDROGENO O UN RESTO ALQUILO CON 1 A 3 ATOMOS DE C, EVENTUALMENTE SUSTITUIDO, O UN GRUPO CARBOXILO, O UN GRUPO -OH, O BIEN FORMA PARTE DE UN RESTO DE CICLOALQUILO. TAMBIEN CONCIERNE LAS SALES DE ACIDO INOFENSIVAS EN FARMACIA, QUE SE DERIVAN DE ELLOS POR ADICION.
ES90107110T 1989-04-21 1990-04-12 Derivados de la pteridina farmaceuticamente eficaces. Expired - Lifetime ES2076247T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3913142A DE3913142A1 (de) 1989-04-21 1989-04-21 Pharmazeutisch wirksame pteridinderivate

Publications (1)

Publication Number Publication Date
ES2076247T3 true ES2076247T3 (es) 1995-11-01

Family

ID=6379151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90107110T Expired - Lifetime ES2076247T3 (es) 1989-04-21 1990-04-12 Derivados de la pteridina farmaceuticamente eficaces.

Country Status (8)

Country Link
US (1) US5124326A (es)
EP (1) EP0393534B1 (es)
JP (1) JPH02292287A (es)
AT (1) ATE124948T1 (es)
CA (1) CA2015049C (es)
DE (2) DE3913142A1 (es)
DK (1) DK0393534T3 (es)
ES (1) ES2076247T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6060454A (en) * 1997-08-08 2000-05-09 Duke University Compositions, apparatus and methods for facilitating surgical procedures
CN106967069A (zh) * 2017-03-22 2017-07-21 盐城市麦迪科化学品制造有限公司 一种氨苯蝶啶的制备方法
CN106977410A (zh) * 2017-05-15 2017-07-25 张家港威胜生物医药有限公司 一种由芴制备本芴醇中间体α‑(二正丁胺基)‑2,7‑二氯‑4‑芴甲醇的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081230A (en) * 1960-09-08 1963-03-12 Smith Kline French Lab Diuretic and antihypertensive triaminoarylpteridines
DE1620667A1 (de) * 1965-12-14 1970-08-20 Dresden Arzneimittel Verfahren zur Herstellung von 2,4,7-Triaminopteridinen
US4252809A (en) * 1977-01-03 1981-02-24 Rohm Pharma Gmbh Substituted pteridine compounds and pharmaceutical compositions containing the same
GB1599881A (en) * 1977-02-02 1981-10-07 Millington A R Preparation for diagnostic radiology
EP0059524A1 (en) * 1981-02-09 1982-09-08 Smith and Nephew Associated Companies p.l.c. Pharmaceutical composition containing aminopteridines or aminopyrimido(4,5-d)pyrimidines
DE3407695A1 (de) * 1984-03-02 1985-09-12 Röhm Pharma GmbH, 6108 Weiterstadt Pteridinverbindungen mit pharmazeutischer wirksamkeit
DE3412765C2 (de) * 1984-04-05 1997-06-05 Roehm Pharma Gmbh Triaminoarylpteridinverbindungen
DE3448490C2 (de) * 1984-04-05 1995-04-27 Roehm Pharma Gmbh Verwendung von Pteridinderivaten zur Behandlung von Herzarrhythmien
DE3740441A1 (de) * 1987-11-28 1989-06-08 Roehm Gmbh Pharmazeutisch wirksame pteridinderivate

Also Published As

Publication number Publication date
DK0393534T3 (da) 1995-10-02
EP0393534A3 (de) 1992-02-26
DE59009388D1 (de) 1995-08-17
US5124326A (en) 1992-06-23
JPH02292287A (ja) 1990-12-03
ATE124948T1 (de) 1995-07-15
DE3913142A1 (de) 1990-10-31
CA2015049C (en) 1997-10-21
EP0393534A2 (de) 1990-10-24
CA2015049A1 (en) 1990-10-21
EP0393534B1 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
GB2262093B (en) Piperazine derivatives
ATE161839T1 (de) 1-(2-(arylsulfonylamino)-1-oxoethyl>piperidin- derivate, ihre herstellung und therapeutische verwendung
DE69522703D1 (de) Aminotetrazol-derivate verwendbar als stickstoff-oxid-synthase inhibitoren
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
AU7379187A (en) Substituted 2-thiazolyl-imidazo{1,2-a}pyrimidine derivatives
ZA926275B (en) Pharmaceutically useful indole derivatives.
TW226015B (es)
ES2076247T3 (es) Derivados de la pteridina farmaceuticamente eficaces.
DK384485A (da) 1,6-naphthyridinderivater med kardilaterende virkning
DK428686A (da) Naphthalenderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393534

Country of ref document: ES